NCT04930991View on ClinicalTrials.gov

High Dose Omeprazole in Patients With Pancreatic Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Exocrine Pancreatic Cancer
Interventions
DRUG

Omeprazole

Treatment will consist of Omeprazole 12-14 days prior to surgical therapy of pancreatectomy.

Trial Locations (1)

73104

RECRUITING

Stephenson Cancer Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER